These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN. Ai K; Zhu X; Kang Y; Li H; Zhang L Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774 [TBL] [Abstract][Full Text] [Related]
25. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related]
26. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
27. TGF-β signaling via TAK1 pathway: role in kidney fibrosis. Choi ME; Ding Y; Kim SI Semin Nephrol; 2012 May; 32(3):244-52. PubMed ID: 22835455 [TBL] [Abstract][Full Text] [Related]
28. Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis. Rayego-Mateos S; Campillo S; Rodrigues-Diez RR; Tejera-Muñoz A; Marquez-Exposito L; Goldschmeding R; Rodríguez-Puyol D; Calleros L; Ruiz-Ortega M Clin Sci (Lond); 2021 Aug; 135(16):1999-2029. PubMed ID: 34427291 [TBL] [Abstract][Full Text] [Related]
29. SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis. Wang TN; Chen X; Li R; Gao B; Mohammed-Ali Z; Lu C; Yum V; Dickhout JG; Krepinsky JC J Am Soc Nephrol; 2015 Aug; 26(8):1839-54. PubMed ID: 25398788 [TBL] [Abstract][Full Text] [Related]
30. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614 [TBL] [Abstract][Full Text] [Related]
31. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028 [TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease. Morinaga J; Kadomatsu T; Miyata K; Endo M; Terada K; Tian Z; Sugizaki T; Tanigawa H; Zhao J; Zhu S; Sato M; Araki K; Iyama K; Tomita K; Mukoyama M; Tomita K; Kitamura K; Oike Y Kidney Int; 2016 Feb; 89(2):327-41. PubMed ID: 26806834 [TBL] [Abstract][Full Text] [Related]
33. The role of endoglin in kidney fibrosis. Muñoz-Felix JM; Oujo B; Lopez-Novoa JM Expert Rev Mol Med; 2014 Dec; 16():e18. PubMed ID: 25439793 [TBL] [Abstract][Full Text] [Related]
34. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells. Luo C; Zhou S; Zhou Z; Liu Y; Yang L; Liu J; Zhang Y; Li H; Liu Y; Hou FF; Zhou L J Am Soc Nephrol; 2018 Apr; 29(4):1238-1256. PubMed ID: 29440280 [TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats. Qi FH; Cai PP; Liu X; Si GM Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600 [TBL] [Abstract][Full Text] [Related]
36. TGF-β: the master regulator of fibrosis. Meng XM; Nikolic-Paterson DJ; Lan HY Nat Rev Nephrol; 2016 Jun; 12(6):325-38. PubMed ID: 27108839 [TBL] [Abstract][Full Text] [Related]
37. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype. Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862 [TBL] [Abstract][Full Text] [Related]
38. Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression Qiu Y; Cao Y; Tu G; Li J; Su Y; Fang F; Zhang X; Cang J; Rong R; Luo Z Front Immunol; 2021; 12():698894. PubMed ID: 34566958 [TBL] [Abstract][Full Text] [Related]
39. Effect of dietary salt on regulation of TGF-β in the kidney. Hovater MB; Sanders PW Semin Nephrol; 2012 May; 32(3):269-76. PubMed ID: 22835458 [TBL] [Abstract][Full Text] [Related]
40. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells. Rhyu DY; Park J; Sharma BR; Ha H Transplant Proc; 2012 Apr; 44(3):625-8. PubMed ID: 22483454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]